Table 4

The clinical and economic outcomes of prevention strategies and control (or compared with control) for subjects at different initiation ages
Screening with diet intervention Screening with exercise intervention Screening with duo-intervention Screening alone Control
Initiation age of 25
 Remaining life yearsI 30.7 30.7 30.7 30.2 29.0
 Costs (US$)II 13294.77 13234.20 13241.38 18973.08 20102.87
(2750.37 - 27317.10) (2744.20 - 27306.59) (2745.42 - 27311.41) (3755.50 - 33613.01) (5334.50 - 37291.10)
 Saving costs(US$)III 6808.10 6868.67 6861.49 1129.79
 QALYsIV 17.98 17.98 17.98 17.05 14.65
(13.00 - 21.40) (13.10 - 23.40) (13.00 - 22.60) (13.20 - 23.00) (11.22 - 19.56)
 Increment QALYsIII 3.33 3.33 3.33 2.40
Initiation age of 40
 Remaining life yearsI 20.1 20.1 20.1 19.7 19.6
 Costs (US$)II 9669.80 9659.97 9731.08 13180.33 13634.36
(2107.23 - 20052.17) (2106.35 - 20048.25) (2109.00 - 20055.12) (3161.46 - 26225.65) (4648.40 - 29925.24)
 Saving costs(US$)III 3964.56 3974.39 3903.28 454.03
QALYs IV 15.47 15.46 15.47 14.25 12.88
(7.96 - 17.56) (7.76 - 17.56) (7.96 - 17.56) (6.84 - 15.64) (6.59 - 15.19)
 Increment QALYsIII 2.59 2.58 2.59 1.37
Initiation age of 60
 Remaining life yearsI 7.5 7.5 7.5 7.4 7.4
 Costs (US$)II 5983.39 5921.23 5928.73 7606.03 8000.42
(1126.44 - 9436.12) (1119.18 - 9425.71) (1119.22 - 9429.12) (1939.74 - 10312.51) (2557.1 -16952.10)
 Saving costs(US$)III 2017.03 2079.19 2071.69 394.39
 QALYsIV 6.32 6.32 6.32 6.09 5.76
(4.26 - 11.33) (4.26 - 11.19) (4.30 - 11.23) (3.41 - 10.12) (3.35 - 9.65)
 Increment QALYsIII 0.56 0.56 0.56 0.33

I: The figures were the mean values of remaining survival years per subject with IGT or diabetes. II: Costs (US$) were the average cost (95% credible intervals) per subject, which arise for subjects from prevention and treatments of diabetes-related disorders during 40 years. III: Saving costs were the average cost per subject in prevention groups in comparison with that of control; Increment QALYs were the average QALYs per subject diagnosed with IGT or diabetes in prevention groups in comparison with that of control. IV: QALYs were the average QALYs per subject with IGT or diabetes (95% credible intervals).

Liu et al.

Liu et al. BMC Public Health 2013 13:729   doi:10.1186/1471-2458-13-729

Open Data